Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cartesian Therapeutics (RNAC) Shares Outstanding (Weighted Average): 2016-2024

Historic Shares Outstanding (Weighted Average) for Cartesian Therapeutics (RNAC) over the last 9 years, with Dec 2024 value amounting to $25.4 million.

  • Cartesian Therapeutics' Shares Outstanding (Weighted Average) rose 6.89% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year increase of 6.89%. This contributed to the annual value of $25.4 million for FY2024, which is 391.25% up from last year.
  • Per Cartesian Therapeutics' latest filing, its Shares Outstanding (Weighted Average) stood at $25.4 million for FY2024, which was up 391.25% from $5.2 million recorded in FY2023.
  • Cartesian Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $25.4 million for FY2024, and its period low was $3.6 million during FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $11.9 million, with a median of $5.2 million in 2023.
  • Data for Cartesian Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 391.25% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Cartesian Therapeutics' Shares Outstanding (Weighted Average) stood at $3.6 million in 2020, then increased by 7.98% to $3.9 million in 2021, then spiked by 31.19% to $5.1 million in 2022, then increased by 1.42% to $5.2 million in 2023, then soared by 391.25% to $25.4 million in 2024.